Table 2 The distribution of biological markers, ET-1 concentration and ACE activity in patients and control subjects
Populations Biological parameters | Patients (n = 157) | Control subjects (n = 142) | p |
|---|---|---|---|
Glucose (x ± σmmolL/) | 9.8 ± 4.2 | 5.40 ± 0.84 | <0000.1 |
TC (x ± σmmol/L) | 5.70 ± 3.1 | 4.60 ± 2.6 | <0.00 |
HDL-C (x ± σmmol/L) | 1.14 ± 0.22 | 1.30 ± 0.41 | NS |
LDL-C (x ± σmmol/L) | 3.60 ± 2.16 | 2.80 ± 1.4 | <0.001 |
TG (x ± σmmol/L) | 1.60 ± 0.9 | 1.24 ± 0.3 | NS |
ApoA1 (x ± σ. g/L) | 1.41 ± 0.62 | 1.80 ± 0.2 | <0000.1 |
ApoB (x ± σ. g/L) | 1.40 ± 0.81 | 0.70 ± 0.2 | <0000.1 |
ET-1 (x ± σ. nM) | 15.2 ± 5.3 | 7.1 ± 2.7 | <0.00001 |
ACE (x ± σ. UI/L) | 86.7 ± 25.4 | 42.8 ± 12.1 | <0.00001 |